Why Agilent Technologies (A) Is On Investors’ Radar Today
Agilent Technologies (A) has drawn fresh attention after recent trading left the stock with negative returns over the month and past 3 months, prompting investors to reassess its current valuation and business profile.
See our latest analysis for Agilent Technologies.
That recent 1 day share price gain of 1.95% and 7 day share price return of 1.29% comes after a 30 day share price return of 7.08% and year to date share price return of 17.22%. The 1 year total shareholder return of 4.47% and 3 year total shareholder return of 11.97% point to momentum that has faded over a longer window.
If this kind of volatility has you comparing opportunities across the market, it can be useful to see how other healthcare related AI names are trading right now with the 36 healthcare AI stocks.
With Agilent trading at $114.20, alongside an indicated 8.9% intrinsic discount and a sizeable gap to analyst targets, the key question is whether the recent share price weakness signals a genuine opportunity or whether the current valuation already reflects expectations for future growth.
Most Popular Narrative: 30.1% Undervalued
With Agilent Technologies last closing at $114.20 against a narrative fair value of about $163.29, the most followed view in the market frames the stock as trading at a sizeable discount based on long term cash flow expectations and margin assumptions.
Strategic investments in higher margin recurring revenue streams including consumables, software, services, and digital platforms are gaining traction, with CrossLab and services delivering consistent mid single digit growth and high customer satisfaction, indicating further margin expansion and greater earnings stability in future periods.
Want to see what kind of revenue mix, profit margins, and earnings multiple need to line up to support that higher value? The narrative sets out a detailed path for earnings growth, recurring cash flows, and required valuation multiples, and the assumptions behind it are far from casual.
Result: Fair Value of $163.29 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this depends on tariff costs and supply chain complexity being contained, and on replacement-driven instrument demand not slowing more than analysts currently assume.
Find out about the key risks to this Agilent Technologies narrative.
Next Steps
If the mixed signals in this article leave you undecided, review the data now and pressure test your own thesis with the 4 key rewards
Looking for more investment ideas?
Do not stop at a single company view. Broaden your watchlist with focused stock ideas that match how you like to invest and the risks you are willing to take.
- Target quality at a discount by scanning for companies with robust fundamentals that still look overlooked using the screener containing 25 high quality undiscovered gems.
- Prioritise resilience by filtering for companies that combine stability with measured risk through the 73 resilient stocks with low risk scores.
- Build a core list of financially sound names by zeroing in on companies with stronger balance sheets using the solid balance sheet and fundamentals stocks screener (39 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com